Tilray Medical has launched Redecan EU-GMP-certified medical cannabis products in Australia.
Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, said, "The launch of Redecan in Australia is a significant milestone for Tilray Medical. The launch of Redecan further expands our medical cannabis portfolios alongside our current Tilray and Broken Coast offerings, as we continue our mission of empowering patients and healthcare practitioners to find the optimal therapeutic solutions."
Jonathan Trodden, Director, Tilray Medical Australia, adds: "We are proud to launch Redecan in Australia and further strengthen our ongoing commitment to providing patients with a consistent, accessible supply of premium quality medical cannabis to choose from."
